Citation Impact
Citing Papers
Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.
1992
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
A Novel Subtype of the Prostacyclin Receptor Expressed in the Central Nervous System
1996 StandoutNobel
Anticoagulant Use in Patients with Chronic Renal Impairment
2005
Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations
2011
A Meta-Analysis of Thromboembolic Prophylaxis Following Elective Total Hip Arthroplasty*
2000
Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty
1998
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Characterization of the Fcγ receptor on human platelets
1990
Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions
2003
Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis
2003
Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro
1997
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Targeted Disruption of Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts
1997 Standout
Early Signs of Brain Infarction at CT: Observer Reliability and Outcome after Thrombolytic Treatment—Systematic Review
2005
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane
1997
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Cellular expression of bone‐related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures
1994
The antisense homology box: A new motif within proteins that encodes biologically active peptides
1995 StandoutNobel
The C. elegans Cell Corpse Engulfment Gene ced-7 Encodes a Protein Similar to ABC Transporters
1998 StandoutNobel
A purine-rich sequence in the human BM-40 gene promoter region is a prerequisite for maximum transcription
1995
The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution
1995
Internal Carotid Artery Stent Implantation in 25 Patients with Acute Stroke: Preliminary Results
2005
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
Coronary heart disease: seven dietary factors
1991 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
Platelet Membrane Glycoproteins: Functions in Cellular Interactions
1990
Prevention of VTE in Nonsurgical Patients
2012 Standout
Cerebral hemorrhagic complications of thrombolytic therapy
1999
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
CD36 is a sensor of diacylglycerides
2005 StandoutNatureNobel
The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation
2002 Standout
Protective and Damaging Effects of Stress Mediators
1998 Standout
The biologic and clinical spectrum of Glanzmann's Thrombasthenia: implications of integrin αIIbβ3 for its pathogenesis
1997
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2012
Pentosan polysulfate‐induced thrombocytopenia and thrombosis
1994
Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator
2004
Adhesion receptors of the immune system
1990 StandoutNature
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Delayed elimination of enoxaparine in patients with chronic renal insufficiency
1991
Enhanced Phagocytosis through Inhibition of de Novo Ceramide Synthesis
2003 StandoutNobel
Carotid endarterectomy and intracranial thrombolysis: Simultaneous and staged procedures in ischemic stroke
1999
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Reversal of Elevated International Normalized Ratios and Bleeding with Low‐Dose Recombinant Activated Factor VII in Patients Receiving Warfarin
2006
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
1993
Monitoring the Anticoagulant Effects of a Low Molecular Weight Heparin Preparation:Correlation of Assays in Orthopedic Surgery Patients Receiving Ardeparin Sodium for Prophylaxis of Deep Venous Thrombosis
1995
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
2003
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
1991 Standout
Mechanisms of Bone Metastasis
2004 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Successful reversal of anticoagulant effect of superwarfarin poisoning with recombinant activated factor VII
2005
Multiple extracellular activities in Drosophila egg perivitelline fluid are required for establishment of embryonic dorsal-ventral polarity
1992 StandoutNobel
Integrins
2002 Standout
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
1992
Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis
2004
Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty
1997
Bilateral vs. ipsilateral venography as the primary efficacy outcome measure in thromboprophylaxis clinical trials: a systematic review
2004
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation
2007
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator
2002
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Reconstitution of liposomes bearing platelet receptors for human von Willebrand factor
1980
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
1984 StandoutNature
Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors.
2000
THROMBOPROPHYLAXIS AND DEATH AFTER TOTAL HIP REPLACEMENT
1996
A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system.
1990 StandoutNobel
Tissue Engineering
1993 StandoutScience
Ether-phospholipid composition in neutrophile and platelets
1985
Thrombocytopenia: Mechanisms and Management of Defects in Platelet Production
1978
Heparin-induced Thrombocytopenia: Towards Consensus
1998
Cytoprotective metal-organic frameworks for anaerobic bacteria
2018 StandoutNobel
Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage
2006
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty
1993
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific
1992
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
1989
Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa Concentrate
2002
Identification and function of the high affinity binding sites for Ca2+ on the surface of platelets.
1984
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
2006
Anticoagulation Monitoring during Cardiac Surgery
1999
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family.
1993
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Symptomatic Intracerebral Hemorrhage in Acute Ischemic Stroke After Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator
2014
Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach
1998
Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets.
1991
Drosophila position-specific antigens resemble the vertebrate fibronectin-receptor family.
1987
Prophylaxis of postoperative thromboembolism with low molecular weight heparins
1993
Acute stroke: evaluation and treatment.
2005
Identification and characterization of a novel antigen complex on mouse mammary tumor cells using a monoclonal antibody against platelet glycoprotein Ic.
1988
Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα
1998
Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, and Other Derivatives of Carbon‐20 Unsaturated Fatty Acids
1982
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
1983
Electrostatic Layer-by-Layer Nanoassembly on Biological Microtemplates: Platelets
2002
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
1996 StandoutScience
Inhibition of lymphocyte-mediated cytolysis by adenosine analogs
1978 StandoutNobel
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
1991
Recombinant human protein C, protein S and thrombomodulin as antithrombotics
1994
Roles of thrombin and platelet membrane glycoprotein IIb/IIIa in platelet-subendothelial deposition after angioplasty in an ex vivo whole artery model.
1991
Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin [see comments]
1988
Determination of the Putative Binding site for Fibronectin on Platelet Glycoprotein IIb-IIIa Complex through a Hydropathic Complementarity Approach
1989
Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein.
1987
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Emergent Use of Anticoagulation for Treatment of Patients With Ischemic Stroke
2002
Low-Molecular-Weight Heparins
1997 Standout
Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
1994
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Nutrients, platelet function and composition in nine groups of French and British farmers
1986
Thrombin Interactions with Platelet Membrane Proteinsa
1986
Prevention of Venous Thromboembolism
1995
Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: Interaction of thrombospondin with fibronectin and collagen
1982
Antibodies to Macromolecular Platelet Factor 4-Heparin Complexes in Heparin-induced Thrombocytopenia: a Study of 44 Cases
1995
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke
2001
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
Intravenous Tirofiban With Intra-Arterial Urokinase and Mechanical Thrombolysis in Stroke
2005
Fish oil consumption and decreased risk of cardiovascular disease: a comparison of findings from animal and human feeding trials
1986
Butter‐enriched diets reduce arterial prostacyclin production in rats
1988
Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes.
1980 StandoutNobel
New Perspectives in Cell Adhesion: RGD and Integrins
1987 StandoutScience
Plasma P-selectin is increased in thrombotic consumptive platelet disorders
1994
Clinical and Vascular Outcome in Internal Carotid Artery Versus Middle Cerebral Artery Occlusions After Intravenous Tissue Plasminogen Activator
2002
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.
1992
A novel flow cytometry–based platelet aggregation assay
2013
Works of M Dechavanne being referenced
Intravenous high-dose igg therapy induced alterations of spleen lymphocyte igm secretion and t cell subsets in patients with idiopathic thrombocytopenic purpura
1987
Increased Plasma Tissue-Type Plasminogen Activator Levels in Patients with Chronic Thrombocytopenia
1990
Complex formation of human thrombospondin with osteonectin
1988
Results of Splenectomy for Idiopathic Thrombocytopenic Purpura
1993
The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
1998
Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery
1989
Human plasma fibrinogen measurement derived from activated partial thromboplastin time clot formation
2002
Prostaglandin E2‐like activity of 20:3n‐9 platelet lipoxygenase end‐product
1985
[In vitro demonstration of anti-platelet antibodies during idiopathic thrombocytopenic purpura by measurement of platelet 14C-serotonin release].
1974
Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis.
1982
Potentiating effect of 5,8,11‐eicosatrienoic acid on human platelet aggregation
1983
Isolation of thrombospondin released from thrombinstimulated human platelets by fast protein liquid chromatography on an anion-exchange mono-q column
1984
Osteonectin is an α-granule component involved with thrombospondin in platelet aggregation
1991
Open Trial of Intravenous Tissue Plasminogen Activator in Acute Carotid Territory Stroke
1996
Identification of human platelet glycoproteins in SDS-polyacrylamide gels using 125I labelled lectins
1979
Pharmacokinetic Studies of Standard Heparin and Low Molecular Weight Heparin in Patients with Chronic Renal Failure
1986
Controlled Trial of Platelet Anti-Aggregating Agents and Subcutaneous Heparin in Prevention of Postoperative Deep Vein Thrombosis in High Risk Patients
1975
Inhibition of thrombin-induced platelet arachidonic acid release by 15-hydroperoxy-arachidonic acid
1981
Polyunsaturated Fatty Acids: Drug or Food?
2015
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid
1984
Pentosane polysulphate associated thrombocytopenia
1986
Thrombolysis With Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke
1998
A comparison of techniques used to study externally oriented proteins and glycoproteins of human blood platelets
1979
Rapid Purification and Partial Characterization of Human Platelet Glycoprotein IIIb
1989
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness
1976
A simple and efficient method for platelet isolation from their plasma
1980
Comparative evaluation of plasma thrombospondin β-thromboglobulin and platelet factor 4 in acute myocardial infarction
1985
Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane.
1993
Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts.
1992
Early Fibrinogen Degradation Coagulopathy Is Predictive of Parenchymal Hematomas in Cerebral rt-PA Thrombolysis
2004
Aggregation to Thrombin and Collagen of Platelets from a Glanzmann Thrombasthenic Patient Lacking Glycoproteins IIb and IIIa
1989
Characterization of human blood platelet membrane proteins and glycoproteins by their isoelectric point (pI) and apparent molecular weight using two-dimensional electrophoresis and surface-labelling techniques
1980
Population Pharmacokinetics of Recombinant Factor VIIa in Volunteers Anticoagulated with Acenocoumarol
1998
Molecular Study of Glanzmann Thrombasthenia in 3 Patients Issued from 2 Different Families
1995
Glycoproteins of Platelet Membranes from Glanzmann's Thrombasthenia. A Comparison with Normal Using Carbohydrate-Specific or Protein-Specific Labelling Techniques and High-Resolution Two-Dimensional Gel Electrophoresis
1981
Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy
1985
Human platelet PGE1 and dihomogammalinolenic acid. Comparison to PGE2 and arachidonic acid
1981
Intravenous plasmin-treated gammaglobulin therapy in idiopathic thrombocytopenic purpura. Results in 40 patients.
1985
Significant Reduction in the Binding of a Monoclonal Antibody (LYP 18) Directed Against the IIb/IIIa Glycoprotein Complex to Platelets of Patients Having Undergone Extracorporeal Circulation
1987
Monoclonal Antibodies against Platelet Membrane Glycoproteins. Characterization and Effect on Platelet Function
1983